“Treatment or Psoriasis With Calcipotriene and Betamethasone Dipropionate (CAL BDP) Cream Showed Significantly Higher Proportion of Patients With an Absolute mPASI≤2 Compared to CAL BDP Gel Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s233. https://doi.org/10.25251/skin.7.supp.233.